Sign in / Join Now
ETFs & Funds
up +35% since 52 week low on 2/7/14. Development in Phase 2 trials?
Add a reply...
Latest StockTalks »
people get QURE breaking news and analysis by email alert.
Get email alerts on QURE »
Get latest price
From other sites
UniQure Announces The Successful Development And Scale-up Of Manufacturing Processes For Its Hemophilia B Gene Therapy Program
at TheStreet (Fri, 7:00AM)
uniQure N.V. (QURE) Shows Strength: Stock Moves 9.1% Higher
at Zacks.com (Thu, 8:20AM)
UniQure Expands Intellectual Property Portfolio With Newly Issued Patent Providing Broad Protection Of Insect Cell-Based AAV Manufacturing
at TheStreet (Jul 18, 2017)
UniQure Presents New Clinical Data In Hemophilia B Patients Demonstrating Therapeutic Efficacy Of AAV5 Gene Therapy In The Presence Of Pre-Existing Neutralizing Antibodies
at TheStreet (Jul 11, 2017)
UniQure Announces Updated, Long-Term Clinical Data From Ongoing Phase I/II Trial Of AMT-060 In Patients With Severe Hemophilia B
at TheStreet (Jul 10, 2017)